Northrop Grumman Corporation
NYSENOC cost to borrow jumps to 0.51% from 0.22% last week, marking a 137% weekly surge amid rising short-covering demand.
Northrop Grumman enters August with a notable tension: the stock is essentially flat on the week while several close defense peers have posted meaningful gains, and a wave of post-earnings analyst target cuts has…
Northrop Grumman reports Q2 results today with the Street divided on a fresh target revision, options hedging still running near its most defensive level of the year, and the stock down 3.1% on the week at $512.29. The…
Snapshot as of 15 Aug 2026
Northrop Grumman heads into Wednesday's Q2 earnings with options traders more cautious than at any point in months, even as the short-selling community remains largely on the sidelines. The options signal is the…
Northrop Grumman heads into Monday's Q2 print having surrendered most of the gains flagged in last week's note, with the stock back at $521.57 after falling 3.3% on the week — a sharp reversal from the $549 close that…
Northrop Grumman has staged a sharp reversal since last week's note: the stock jumped 7.8% to close at $549.04, recouping most of what it lost through June and closing the gap to peers who have also had a strong week…
Northrop Grumman heads into its July 21 earnings report carrying a month of underperformance, a steady stream of analyst target cuts, and a short position that has quietly grown — setting up a stock where the Street…
Northrop Grumman heads into its July 23 earnings report with the Street broadly bullish but visibly less confident — a gap between consensus targets and the current price that tells the real story this week. The…
Northrop Grumman has just printed its May 20 earnings event, and the week's most important development is a sharp reversal in options sentiment — from call-led optimism into renewed caution — even as the borrow market…
Northrop Grumman arrives at its May 20 earnings report carrying a 20% one-month price decline — the deepest single-month loss among major US defense primes — and a Street still collectively pointing to targets well…
Northrop Grumman Corporation enters the week trading at $558.30, still nursing a 17% one-month decline after a Q1 earnings print that hit investors hard — and with another earnings event just one week away. The story…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NOC — free to start on ORTEX.
Sign up for free →Open NOC on ORTEX